Department of Biotechnology India invited proposals under the DBT-UMMID Initiative

Congenital and hereditary genetic diseases are a significant health burden in India. Therefore, there is a need for adequate and effective genetic testing and counseling services. The diagnostic tests for many of the genetic disorders available in India are at a relatively nascent stage. While antenatal diagnostics for a few genetic diseases are available, these are available in very few hospitals. Considering these facts, the Department, in the year 2019, launched the DBT-UMMID initiative with the objectives of establishing Genetic Diagnostic Units (NIDAN Kendras) in Government Hospitals, producing skilled clinicians in the area of Human Genetics (Biochemical Genetics, Cytogenetics, Molecular Genetics, Clinical Genetics and Comprehensive Clinical Care), and screening of pregnant women and newborn babies for diagnosis of inherited genetic diseases in aspirational districts to provide comprehensive clinical care. Now, the Department of Biotechnology, in the next phase of UMMID initiative, is
desirous of expansion of the program across the country. Under the present call, the

Department invites R&D proposals in the following areas:
1. Establishment of DBT-NIDAN Kendras
2. Screening of pregnant women and newborns in Aspirational Districts
3. Establishment of Training Centres on Clinical Genetics

Intrested institutions should submit project proposals online by nominating Project Coordinator and Principal Investigator(s)/Co-Principal Investigator(s)/ Coinvestigator(s) who can submit proposals through DBT electronic project management system ‘eProMIS’ ( under the Programme ‘Human Genetics and Genome Analysis’.

In addition to submitting the proposal in the R&D project format available on the DBT e-ProMIS portal, the format at Annexure –I should also be also completed, duly endorsed and submitted by uploading on the e-ProMIS portal as a PDF file. The Consolidated PDF and MS Word files of the proposal with all the enclosures and the Annexure-I (duly completed and endorsed) must also be sent via email on the email IDs: with a copy to within last date of submission.

Contact for furher information: Dr. Onkar N. Tiwari, Scientist ‘E’, DBT, New Delhi (Email ID: Tel.: +91-11-24361290) or Dr. Amit K. Tripathi, Scientist ‘C’, DBT, New Delhi (Email ID:

Details on following links:

Leave a Reply

Your email address will not be published. Required fields are marked *